CT SB00847

Expands newborn screening requirements to include amino acid disorders, organic acid disorders, fatty acid oxidation disorders (L-CHAD and MCAD), and other metabolic and genetic disorders listed on the federal recommended uniform screening panel per 42 USC 300b-10, in addition to existing tests for HIV, phenylketonuria, hypothyroidism, galactosemia, and sickle cell disease.

Requires blood spot specimens be collected between 24 and 48 hours after birth, with exceptions allowed for medical contraindications, imminent transfusions, early discharge, transfer to another institution, or imminent death; institutions must notify the Department of Public Health within 72 hours if specimen collection is delayed.

Sets minimum fees charged to institutions at $98 to cover all expenses of the comprehensive screening program including testing, tracking, and treatment.

Requires screening for cystic fibrosis and critical congenital heart disease, and mandates screening for cytomegalovirus in newborns who fail hearing screening tests.

Exempts newborns from screening requirements if parents object based on religious tenets and practices; effective date is October 1, 2021.